Biomonitoring Equivalents for bisphenol A (BPA)

Regulatory Toxicology and Pharmacology

Volumn 58, Issue 1, 2010, Pages 18-24

  Krishnan, Kannan ^a   Gagné, Michelle ^a   Nong, Andy ^b   Aylward, Lesa L ^c   Hays, Sean M ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HEALTH CANADA   (Canada)

^c LLP   (United States)

Author keywords

Biomonitoring Equivalents; Bisphenol A; Pharmacokinetics; Risk assessment

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BIOLOGICAL MARKER; CREATININE;

ARTICLE; BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; NONHUMAN; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; STANDARDIZATION; TOXICOKINETICS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; ENVIRONMENTAL POLLUTION; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOLS; REFERENCE VALUES; RISK ASSESSMENT; YOUNG ADULT;

EID: 77955920482     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.06.005     Document Type: Article

References (46)

1. ACGIH, 2007. Documentation of the TLVs and BEIs with Other Worldwide Occupational Exposure Values. ACGIH, Cincinnati, OH.
2. Arakawa C., Fujimaki K., Yoshinaga J., Imai H., Serizawa S., Shiraishi H. Daily urinary excretion of bisphenol A. Environ. Health Preventive Medicine 2004, 9:22-26.
3. Aylward L.L., Hays S.M. Biomonitoring equivalents (BE) dossier for 2, 4-dichlorophenoxyacetic acid 92, 4-D) (CAS No. 94-75-7). Regul Toxicol Pharm 2008, 51:S37-S48.
4. Aylward L.L., Hays S.M., Gagné M., Krishnan K. Derivation of biomonitoring equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). Regul. Toxicol. Pharmacol. 2009, 55:249-258.
5. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
6. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005, 113:391-395.
7. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the US population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 2008, 116:39-44.
8. Center For The Evaluation of Risks To Human Reproduction National Toxicology Program (CERHR). 2008. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. U.S. Department of Health and Human Services NIH Publication No. 08-59.
9. Cho C.Y., Shin B.S., Jung J.H., Kim D.H., Lee K.C., Han S.Y., Kim H.S., Lee B.M., Yoo S.D. Pharmacokinetic scaling of bisphenol A by species-invariant time methods. Xenobiotica 2002, 32:925-934.
10. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol. 2008, 228:114-134.
11. Edginton A.N., Ritter L. Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ. Health Perspect. 2009, 117:645-652.
12. European Food Safety Authority (EFSA). 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to,2-BIS(4-HYDROXYPHENYL)PROPANE (Bisphenol A). Available at: (May 19th, 2009). http://www.efsa.europa.eu/cs/BlobServer/Scientific_Opinion/afc_op_ej428_bpa_op_en,3.pdf?ssbinary=true.
13. European Food Safety Authority (EFSA). 2008. Toxicokinetics of Bisphenol A. Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC). Available at: (June 17th, 2010). http://www.efsa.europa.eu/en/scdocs/doc/759.pdf.
14. Garde A.H., Hansen A.M., Kristiansen J., Knudsen L.E. Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration. Ann. Occup. Hyg. 2004, 48:171-179.
15. Haighton L.A., Hlywka J.J., Doull J., Kroes R., Lynch B.S., Munro I.C. An evaluation of the possible carcinogenicity of bisphenol A to humans. Regul. Toxicol. Pharmacol. 2002, 35:238-254.
16. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk P.J., Dizio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., Yager J.W. Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop. Regul. Toxicol. Pharmacol. 2008, 51:S4-S15.
17. Health Canada, 2008. Health Risk Assessment of Bisphenol A from Food Packaging Applications. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch. Available at: (May 19th, 2009). http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/securit/bpa_hra-ers-eng.pdf.
18. Inoue H., Tsuruta A., Kudo S., Ishii T., Fukushima Y., Iwano H., Yokota H., Kato S. Bisphenol A glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab. Dispos. 2004, 33:55-59.
19. Kawamoto Y., Matsyama W., Wada M., Hishikawa J., Chan M.P.L., Nakayama A., Morisawa S. Development of a physiologically-based pharmacokinetic model for bisphenol A in pregnant mice. Toxicol. Appl. Pharmacol. 2007, 224:182-191.
20. Knaak B., Sullivan L.J. Metabolism of bisphenol A in the rat. Toxicol. Appl. Pharmacol. 1966, 8:175-184.
21. Kuester R.K., Sipes I.G. Prediction of metabolic clearance of bisphenol A using cryopreserved human hepatocytes. Drug Metab. Dispos. 2007, 35:1910-1915.
22. Kurebayashi H., Betsui H., Ohno Y. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Toxicol Sci. 2003, 73:17-25.
23. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstein D.A., Kilpatrick M.E., Krewski D., Bartels M.J., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W., Hays S.M. Guidelines for the communication of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop. Regul. Toxicol. Pharmacol. 2008, 51:S16-S26.
24. Lakind J.S., Naiman D.Q. Bisphenol A (BPA) daily intakes in the United States: estimates from the 2003-2004 NHANES urinary BPA data. J. Expo. Sci. Environ. Epidemiol. 2008, 18:608-615.
25. Mage D.T., Allen R.H., Gondy G., Smith W., Barr D.B., Needham L.L. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J. Expo. Anal. Environ. Epidemiol. 2004, 14:457-465.
26. Mahalingaiah S., Meeker J.D., Pearson K.R., Calafat A.M., Ye X., Petrozza J., Hauser R. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ. Health Perspect. 2008, 116:173-178.
27. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite bisphenol A glucuronide with estrogen receptors α and β. Chem. Res. Toxicol. 2001, 14:149-157.
28. Mielke H., Gundert-Remy U. Bisphenol A levels in blood depend on age and exposure. Toxicol. Lett. 2009, 190(1):32-40.
29. Ministry of Economy, Trade and Industry (METI) 2002. Risk assessment of endocrine disruptors. Available at: [Accessed 25 May 2010]. http://www.meti.go.jp/english/report/data/g020205ae.html.
30. National Toxicology Program (NTP), 1982, Carcinogenesis Bioassay of Bisphenol A (CAS No. 80-05-7) in F344 Rats and B6C3F1 Mice (Feed Study), Tech Rept No TR-215, Research Triangle Park, NC.
31. Perucca J., Bouby N., Valeix P., Bankir L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R700-R705.
32. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 2000, 54:3-18.
33. Remer T., Fonteyn N., Alexy U., Berkemeyer S. Longitudinal examination of 24-h urinary iodine excretion in schoolchildren as a sensitive, hydration status-independent research tool for studying iodine status. Am. J. Clin. Nutr. 2006, 83:639-646.
34. Remer T., Neubert A., Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 2002, 75:561-569.
35. Sharpe R.M. Is it time to end concerns over the estrogenic effects of bisphenol A?. Toxicol. Sci. 2010, 114:1-4.
36. Shin B.S., Kim C.H., Jun Y.S., Kim D.H., Lee B.M., Yoon C.H., Park E.H., Lee K.C., Han S.Y., Park K.L., Kim H.S., Yoo S.D. Physiologically based pharmacokinetics of bisphenol A. J. Toxicol. Environ. Health A. 2004, 67:1971-1985.
37. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C.J., Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 2000, 168:225-234.
38. Teeguarden J.G., Waechter J.M., Clewell H.J., Covington T.R., Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 2005, 85:823-838.
39. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., Veselica M.M., Fail P.A., Chang T.Y., Seely J.C., Joiner R.L., Butala J.H., Dimond S.S., Cagen S.Z., Shiotsuka R.N., Stropp G.D., Waechter J.M. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol. Sci. 2002, 68:121-146.
40. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., Waechter J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 2008, 104:362-384.
41. US EPA, 1993. Available at: (May 19th, 2009). http://www.epa.gov/iris/subst/0356.htm.
42. US EPA 2008. Child-specific exposure factors handbook. National Center for Environmental Assessment, Office of Research and Development. EPA/600/R-06/096F.
43. Völkel W., Bittner N., Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry.Drug. Metab. Dispos. 2005, 33:1748-1757.
44. Völkel W., Colnot T., Csanády G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.
45. Völkel,W., Kiranoglu, M., Fromme, H., 2008. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol. Lett. 10;179, 155-162.
46. Willhite C.C., Ball G.L., McLellan C.J. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. J. Toxicol. Environ. Health B Crit. Rev. 2008, 11:69-146.